Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesRadiology/Diagnostic ImagingBlue Cross Blue Shield OK advanced imaging Prior A…
    Ask Trek AI about this page
    ModifiedBlue Cross Blue Shield - OklahomaPolicy N/A

    Advanced Imaging / Radiology prior authorization code list

    Customize your policy alerts

    Sign up for all Blue Cross Blue Shield - Oklahoma policy alerts

    Know when Blue Cross Blue Shield - Oklahoma releases new policies or updates existing guidance.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    A list of CPT/HCPCS procedure codes related to advanced imaging/radiology services for which prior authorization may be required for Blue Cross and Blue Shield of Oklahoma networks; applies to providers and facilities performing these imaging services.

    Policy Summary
    PayerBlue Cross Blue Shield - Oklahoma
    PolicyAdvanced Imaging / Radiology prior authorization code list
    Policy CodePolicy N/A
    Change TypeMaterial updates to code management and criteria
    Effective DateJan 1, 2025
    Next Review DateN/A
    Key ActionDocument medical necessity requests with site-of-care and route prior authorization requests to the entity listed in 'Managed By' (predominantly Carelon).
    SourceLink
    POLICY UPDATE CHANGES

    Addition of site of care to the medical necessity criteria for multiple advanced imaging CPT codes effective 01/01/2025.

    Effective 01/01/2025, addition of site of care to the medical necessity criteria for multiple advanced imaging CPT codes.

    PLA codes 0552U, 0553U, 0554U, and 0555U were added to the managed codes list with an effective date of 10/1/2025.

    CPT 92633 is marked 'Retire Effective 01/01/2025'.

    Multiple new U-codes (0552U–0569U, 0571U) and 81195 added effective 04/01/2025 or 10/01/2025.

    Multiple new Category III (0###U) and other codes were added with specified effective dates (e.g., 0476U, 0477U, 0478U, 0481U, 0485U, 0486U, 0487U, 0488U, 0489U, 0493U, 0494U, 0496U, 0497U, 0498U, 0499U, 0500U, 0506U, 0507U, 0508U, 0509U, 0516U, 0523U, 0529U, 0530U, 0532U, 0533U, 0534U, 0536U, 0537U, 0538U, 0539U, 0540U, 0543U, 0544U, 0549U, 0627T-0630T).

    0456U was marked 'Retire Effective 04/01/2025'.

    01/01/2025Date of update adding site-of-care requirement for many codes
    4PLA codes added effective 10/01/2025
    1Codes retired effective 01/01/2025
    CarelonUtilization management vendor for listed codes
    ~100+Advanced imaging CPT codes listed (partial)

    Coverage Criteria and Management Assignments

    Site-of-care inclusion in medical necessity criteria

    Medical necessity criteria for the listed advanced imaging codes include site-of-care as an added requirement effective 01/01/2025.

    site_of_care_added: Site of care must be included in the medical necessity criteria for authorization/coverage decisions for the listed CPT codes.effective 01/01/2025

    Operational requirement run by Carelon

    Management assignment (informational)

    Codes listed are subject to utilization management by the named manager

    Managed codes: Each listed CPT/HCPCS/PLA code is subject to the utilization management process of the entity indicated by 'Managed By' (Carelon or BCBSOK).

    No additional clinical criteria present in this fragment.

    Utilization management assignments

    Listed molecular genetic tests are included in the utilization management process and assigned to a manager for review

    Assignment and effective dates: Each listed code includes a 'Managed By' designation (predominantly Carelon) and some codes have specified effective add dates (e.g., multiple 05xxx U-codes effective 10/01/2025; 81195 effective 04/01/2025).

    Providers must route management/authorization per the 'Managed By' field.

    Panel gene-list coverage criteria

    Coverage and ordering expectations include required minimum gene content for named panels

    Panel-specific gene inclusion requirement: For specified CPT panel codes the genomic sequence analysis must include sequencing (or duplication/deletion analysis if specified) of the minimum named gene set for that indication (examples: 81410 requires >=9 named genes for aortic dysfunction; 81430 requires >=60 genes for hearing loss; 81440 requires >=100 genes for nuclear-encoded mitochondrial genes).see code-specific entries

    Exact gene lists are provided per code in the policy text.

    The reviewed document segment does not enumerate any explicit modality- or indication-based exclusions. In other words, within the cited material there are no listed tests or imaging modalities identified as specifically excluded from coverage or utilization management; the content instead provides managed-code listings and management assignments (e.g., many advanced imaging CPT codes are shown as "Managed By = Carelon"). Providers should rely on code-level entries and the assigned manager for route-of-authorization and any further exclusion language elsewhere in the full policy file.

    The document marks CPT code 92633 as retired: the entry shows "Updates = Retire Effective 01/01/2025." Operationally, that retirement indicates 92633 will be removed from active managed-code listings after 01/01/2025 and should not be included in authorization routing or active utilization management beyond that effective date.

    This portion of the file is a catalog-style listing of molecular/PLA codes with their short descriptions and management attributions. The cited chunks list codes and note the entity responsible for utilization management (for many entries this is Managed By = Carelon), but they do not state independent coverage exclusions or explicit clinical necessity rules in this excerpt.

    The excerpt provides a sequence of molecular genetic CPT codes with descriptions and shows each code’s management assignment (for example, many entries are labeled Managed By = Carelon), but it does not contain explicit coverage decision language (such as 'covered' or 'not medically necessary') in the cited material. Use the code descriptions and the 'Managed By' field to route authorization requests to the correct manager.

    Several U-/Category III codes in this segment are annotated with scheduled retirements. Examples in the cited material include entries marked "Updates = Retire Effective 04/01/2025" (e.g., 0380U, 0448U, and 0456U) and similar retirement notes. These retirement annotations indicate those codes will be removed from active management after the specified dates and should be treated as retired for authorization and claims processing beginning on the listed effective retire date.

    Code 0078U is shown with a retirement annotation: the listing includes "Updates = Retire Effective 07/01/2025." This indicates 0078U will be retired effective July 1, 2025 and may be removed from active coverage/management listings after that date; providers and billing staff should not submit this code for management as an active code past the retirement effective date.

    These chunks present a catalog of U-codes and descriptive text for numerous molecular genetic tests and panels. The entries provide code descriptions and indicate management attribution (predominantly Managed By = Carelon), but within these excerpts there are no standalone coverage rules or medical necessity criteria; they serve primarily as code-level identifiers and routing information for utilization management.

    The cited material shows multiple codes annotated with retirement or future effective-date notes. Examples include 0456U (Retire Effective 04/01/2025) and other Category III entries with retire or add-effective annotations. These notes indicate the document’s operational handling for those codes—retired codes will be removed from active management on the listed dates and new codes will require routing per their specified effective dates.

    The excerpt shows code-level panel requirements (for example, hearing-loss and hereditary cancer panels) and does not include explicit statements declaring any listed test as 'not medically necessary.' The content focuses on minimum gene-content expectations for specified genomic panels and management attributions rather than exclusionary coverage determinations.

    In the cited material there are no explicit statements labeling any listed tests as not medically necessary. The content is a managed-code catalog (U-codes) with descriptions and 'Managed By' assignments; clinical determinations of medical necessity would be made through the utilization management process referenced by the 'Managed By' entries.

    Note

    Searchable file — use code or description to check PA

    This file is a searchable PDF; providers can search by procedure code or description to determine whether prior authorization is required.

    General listing of imaging types subject to utilization management

    imaging_types_listed: CT, MRI, MRA, PET, ultrasound, and nuclear medicine procedures (as listed in the searchable file) are subject to utilization management; providers should reference the searchable list to determine whether a specific code/indication requires authorization.

    This file is searchable by procedure code or description.

    Cardiac PET and echocardiography

    cardiac_pet_echocardiography: Cardiac PET myocardial perfusion codes and transthoracic/transesophageal echocardiography codes are managed per the listed 'Managed By' assignment (managed by Carelon in the listed entries).

    No additional clinical indication thresholds are specified in these chunks.

    Code Listings and Effective Dates

    Example code (partial list)CPT
    70336Magnetic Resonance (Eg Proton) Imaging
    CT and MR head/face/orbit/maxillofacial codes (partial)CPT
    70450Computed Tomography Head Or Brain; Without Contrast Material
    70460Computed Tomography Head Or Brain; With Contrast Material(S)
    70470Computed Tomography Head Or Brain; Without Contrast Material Followed By Contrast Material(S) And Further Sections
    70480Computed Tomography Orbit Sella Or Posterior Fossa Or Outer Middle Or Inner Ear; Without Contrast Material
    70481Computed Tomography Orbit Sella Or Posterior Fossa Or Outer Middle Or Inner Ear; With Contrast Material(S)
    70482Computed Tomography Orbit Sella Or Posterior Fossa Or Outer Middle Or Inner Ear; Without Contrast Material Followed By Contrast Material(S)
    70486Computed Tomography Maxillofacial Area; Without Contrast Material
    Advanced Imaging CPT codes (partial list)CPT
    70540Magnetic Resonance (Eg Proton) Imaging Orbit Face And/Or Neck; Without Contrast Material(S)
    70542Magnetic Resonance (Eg Proton) Imaging Orbit Face And/Or Neck; With Contrast Material(S)
    70543Magnetic Resonance (Eg Proton) Imaging Orbit Face And/Or Neck; Without Contrast Material(S) Followed By Contrast Material(S) And Further Sequences
    70544Magnetic Resonance Angiography Head; Without Contrast Material(S)
    70545Magnetic Resonance Angiography Head; With Contrast Material(S)
    70546Magnetic Resonance Angiography Head; Without Contrast Material(S) Followed By Contrast Material(S) And Further Sequences
    70547Magnetic Resonance Angiography Neck; Without Contrast Material(S)
    70548Magnetic Resonance Angiography Neck; With Contrast Material(S)
    70549Magnetic Resonance Angiography Neck; Without Contrast Material(S) Followed By Contrast Material(S) And Further Sequences
    70551Magnetic Resonance (Eg Proton) Imaging Brain (Including Brain Stem); Without Contrast Material
    1–10 of 40
    1/4
    Advanced Imaging CPT codes (sample, upper extremity)CPT
    73223Magnetic Resonance (Eg Proton) Imaging Any Joint Of Upper Extremity; Without Contrast Material(s) Followed By Contrast Material(s) And Further Sequences.
    73225Magnetic Resonance Angiography Upper Extremity With Or Without Contrast Material(s).
    Advanced Imaging CPT codes (lower extremity group)CPT
    73700Computed Tomography Lower Extremity; Without Contrast Material.
    73701Computed Tomography Lower Extremity; With Contrast Material(s).
    73702Computed Tomography Lower Extremity; Without Contrast Material Followed By Contrast Material(s) And Further Sections.
    73706Computed Tomographic Angiography Lower Extremity With Contrast Material(s) Including Noncontrast Images If Performed And Image Postprocessing.
    73718Magnetic Resonance (Eg Proton) Imaging Lower Extremity Other Than Joint; Without Contrast Material(s).
    73719Magnetic Resonance (Eg Proton) Imaging Lower Extremity Other Than Joint; With Contrast Material(s).
    73720Magnetic Resonance (Eg Proton) Imaging Lower Extremity Other Than Joint; Without Contrast Material(s) Followed By Contrast Material(s) And Further Sequences.
    73721Magnetic Resonance (Eg Proton) Imaging Any Joint Of Lower Extremity; Without Contrast Material.
    73722Magnetic Resonance (Eg Proton) Imaging Any Joint Of Lower Extremity; With Contrast Material(s).
    73723Magnetic Resonance (Eg Proton) Imaging Any Joint Of Lower Extremity; Without Contrast Material(s) Followed By Contrast Material(s) And Further Sequences.
    1–10 of 11
    1/2
    Advanced Imaging CPT codes (abdomen/pelvis group)CPT
    74150Computed Tomography Abdomen; Without Contrast Material.
    74160Computed Tomography Abdomen; With Contrast Material(s).
    74170Computed Tomography Abdomen; Without Contrast Material Followed By Contrast Material(s) And Further Sections.
    74174Computed Tomographic Angiography Abdomen And Pelvis With Contrast Material(s) Including Noncontrast Images If Performed And Image Postprocessing.
    74175Computed Tomographic Angiography Abdomen With Contrast Material(s) Including Noncontrast Images If Performed And Image Postprocessing.
    74176Computed Tomography Abdomen And Pelvis; Without Contrast Material.
    74177Computed Tomography Abdomen And Pelvis; With Contrast Material(s).
    74178Computed Tomography Abdomen And Pelvis; Without Contrast Material In One Or Both Body Regions Followed By Contrast Material(s) And Further Sections In One Or Both Body Regions.
    74181Magnetic Resonance (Eg Proton) Imaging Abdomen; Without Contrast Material(s).
    74182Magnetic Resonance (Eg Proton) Imaging Abdomen; With Contrast Material(s).
    1–10 of 12
    1/2
    CT/MR colonography, fetal MRI, and CTA aorta codesCPT
    74261Computed Tomographic (CT) Colonography Diagnostic Including Image Postprocessing; Without Contrast Material.
    74262Computed Tomographic (CT) Colonography Diagnostic Including Image Postprocessing; With Contrast Material(s) Including Non-Contrast Images If Performed.
    74263Computed Tomographic (CT) Colonography Screening Including Image Postprocessing.
    74712Magnetic Resonance (Eg Proton) Imaging Fetal Including Placental And Maternal Pelvic Imaging When Performed; Single Or First Gestation.
    74713Magnetic Resonance (Eg Proton) Imaging Fetal Including Placental And Maternal Pelvic Imaging When Performed; Each Additional Gestation.
    75635Computed Tomographic Angiography Abdominal Aorta And Bilateral Iliofemoral Lower Extremity Runoff With Contrast Material(s) Including Noncontrast Images If Performed And Image Postprocessing.
    3D rendering and advanced MR technique codesCPT
    763763D Rendering With Interpretation And Reporting Of Computed Tomography Magnetic Resonance Imaging Ultrasound Or Other Tomographic Modality With Image Postprocessing Under Concurrent Supervision; Not Requiring Image Postprocessing On An Independent Workstation.
    763773D Rendering With Interpretation And Reporting Of Computed Tomography Magnetic Resonance Imaging Ultrasound Or Other Tomographic Modality With Image Postprocessing Under Concurrent Supervision; Requiring Image Postprocessing On An Independent Workstation.
    76380Computed Tomography Limited Or Localized Follow-Up Study.
    76390Magnetic Resonance Spectroscopy.
    76391Magnetic Resonance (Eg Vibration) Elastography.
    Breast MRI and bone density codesCPT
    77046Magnetic Resonance Imaging Breast Without Contrast Material; Unilateral.
    77047Magnetic Resonance Imaging Breast Without Contrast Material; Bilateral.
    77048Magnetic Resonance Imaging Breast Without And With Contrast Material(s) Including Computer-Aided Detection (CAD) Real-Time Lesion Detection Characterization And Pharmacokinetic Analysis; Unilateral.
    77049Magnetic Resonance Imaging Breast Without And With Contrast Material(s) Including Computer-Aided Detection (CAD) Real-Time Lesion Detection Characterization And Pharmacokinetic Analysis; Bilateral.
    77078Computed Tomography Bone Mineral Density Study 1 Or More Sites Axial Skeleton (Eg Hips Pelvis Spine).
    77084Magnetic Resonance (Eg Proton) Imaging Bone Marrow Blood Supply.
    Thyroid imaging and nuclear medicine codesCPT
    78012Thyroid Uptake Single Or Multiple Quantitative Measurement(s) (Including Stimulation Suppression Or Discharge When Performed).
    78013Thyroid Imaging (Including Vascular Flow When Performed).
    78014Thyroid Imaging (Including Vascular Flow When Performed); With Single Or Multiple Uptake(s) Quantitative Measurement(s) (Including Stimulation Suppression Or Discharge When Performed).
    78015Thyroid Carcinoma Metastases Imaging; Limited Area (Eg Neck And Chest Only).
    78016Thyroid Carcinoma Metastases Imaging; With Additional Studies (Eg Urinary Recovery).
    78018Thyroid Carcinoma Metastases Imaging; Whole Body.
    78020Thyroid Carcinoma Metastases Uptake (List Separately In Addition To Code For Primary Procedure).
    Parathyroid, adrenal, and bone marrow imaging codesCPT
    78070Parathyroid Planar Imaging (Including Subtraction When Performed).
    78071Parathyroid Planar Imaging (Including Subtraction When Performed); With Tomographic (SPECT).
    78072Parathyroid Planar Imaging (Including Subtraction When Performed); With Tomographic (SPECT) And Concurrently Acquired Computed Tomography (CT) For Anatomical Localization.
    78075Adrenal Imaging Cortex And/Or Medulla.
    78102Bone Marrow Imaging; Limited Area.
    78103Bone Marrow Imaging; Multiple Areas.
    78104Bone Marrow Imaging; Whole Body.
    Abdominal nuclear medicine and organ imaging codesCPT
    78185Spleen Imaging Only With Or Without Vascular Flow.
    78195Lymphatics And Lymph Nodes Imaging.
    78201Liver Imaging; Static Only.
    78202Liver Imaging; With Vascular Flow.
    78215Liver And Spleen Imaging; Static Only.
    78216Liver And Spleen Imaging; With Vascular Flow.
    78226Hepatobiliary System Imaging Including Gallbladder When Present.
    78227Hepatobiliary System Imaging Including Gallbladder When Present; With Pharmacologic Intervention Including Quantitative Measurement(s) When Performed.
    GI motility and salivary imaging codesCPT
    78230Salivary Gland Imaging.
    78231Salivary Gland Imaging; With Serial Images.
    78232Salivary Gland Function Study.
    78258Esophageal Motility.
    78261Gastric Mucosa Imaging.
    78262Gastroesophageal Reflux Study.
    78264Gastric Emptying Imaging Study (Eg Solid Liquid Or Both).
    78265Gastric Emptying Imaging Study (Eg Solid Liquid Or Both); With Small Bowel Transit.
    78266Gastric Emptying Imaging Study (Eg Solid Liquid Or Both); With Small Bowel And Colon Transit Multiple Days.
    Additional GI imaging codesCPT
    78278Acute Gastrointestinal Blood Loss Imaging.
    78290Intestine Imaging (Eg Ectopic Gastric Mucosa Meckel's Localization Volvulus).
    78291Peritoneal-Venous Shunt Patency Test (Eg For Leveen Denver Shunt).
    Bone/joint and venous imaging codesCPT
    78300Bone And/Or Joint Imaging; Limited Area.
    78305Bone And/Or Joint Imaging; Multiple Areas.
    78306Bone And/Or Joint Imaging; Whole Body.
    78315Bone And/Or Joint Imaging; 3 Phase Study.
    78445Non-Cardiac Vascular Flow Imaging (Ie Angiography Venography).
    78456Acute Venous Thrombosis Imaging Peptide.
    78457Venous Thrombosis Imaging Venogram; Unilateral.
    78458Venous Thrombosis Imaging Venogram; Bilateral.
    Pulmonary and brain imaging codesCPT
    78579Pulmonary Ventilation Imaging (Eg Aerosol Or Gas).
    78580Pulmonary Perfusion Imaging (Eg Particulate).
    78582Pulmonary Ventilation (Eg Aerosol Or Gas) And Perfusion Imaging.
    78597Quantitative Differential Pulmonary Perfusion Including Imaging When Performed.
    78598Quantitative Differential Pulmonary Perfusion And Ventilation (Eg Aerosol Or Gas) Including Imaging When Performed.
    78600Brain Imaging Less Than 4 Static Views.
    78601Brain Imaging Less Than 4 Static Views; With Vascular Flow.
    78605Brain Imaging Minimum 4 Static Views.
    78606Brain Imaging Minimum 4 Static Views; With Vascular Flow.
    Brain, CSF, and renal imaging codesCPT
    78608Brain Imaging Positron Emission Tomography (PET); Metabolic Evaluation.
    78609Brain Imaging Positron Emission Tomography (PET); Perfusion Evaluation.
    78610Brain Imaging Vascular Flow Only.
    78630Cerebrospinal Fluid Flow Imaging (Not Including Introduction Of Material); Cisternography.
    78635Cerebrospinal Fluid Flow Imaging (Not Including Introduction Of Material); Ventriculography.
    78645Cerebrospinal Fluid Flow Imaging (Not Including Introduction Of Material); Shunt Evaluation.
    78650Cerebrospinal Fluid Leakage Detection And Localization.
    78660Radiopharmaceutical Dacryocystography.
    78700Kidney Imaging Morphology.
    78701Kidney Imaging Morphology; With Vascular Flow.
    1–10 of 12
    1/2
    Advanced nuclear/brain imaging codesCPT
    78597Managed By = Carelon
    78598Quantitative Differential Pulmonary Perfusion And Ventilation (Eg Aerosol Or Gas) Including Imaging When Performed. Managed By = Carelon
    78600Brain Imaging Less Than 4 Static Views. Managed By = Carelon
    78601Brain Imaging Less Than 4 Static Views; With Vascular Flow. Managed By = Carelon
    78605Brain Imaging Minimum 4 Static Views. Managed By = Carelon
    78606Brain Imaging Minimum 4 Static Views; With Vascular Flow. Managed By = Carelon
    78608Brain Imaging Positron Emission Tomography (PET); Metabolic Evaluation. Managed By = Carelon
    78609Brain Imaging Positron Emission Tomography (PET); Perfusion Evaluation. Managed By = Carelon
    78610Brain Imaging Vascular Flow Only. Managed By = Carelon
    Cerebrospinal and renal nuclear imagingCPT
    78630Cerebrospinal Fluid Flow Imaging; Cisternography. Managed By = Carelon
    78635Cerebrospinal Fluid Flow Imaging; Ventriculography. Managed By = Carelon
    78645Cerebrospinal Fluid Flow Imaging; Shunt Evaluation. Managed By = Carelon
    78650Cerebrospinal Fluid Leakage Detection And Localization. Managed By = Carelon
    78660Radiopharmaceutical Dacryocystography. Managed By = Carelon
    78700Kidney Imaging Morphology. Managed By = Carelon
    78701Kidney Imaging Morphology; With Vascular Flow. Managed By = Carelon
    78707Kidney Imaging Morphology; With Vascular Flow And Function Single Study Without Pharmacological Intervention. Managed By = Carelon
    78708Kidney Imaging Morphology; With Vascular Flow And Function Single Study With Pharmacological Intervention. Managed By = Carelon
    78709Kidney Imaging Morphology; With Vascular Flow And Function Multiple Studies With And Without Pharmacological Intervention. Managed By = Carelon
    Tumor/inflammatory localization and related nuclear medicineCPT
    78725Kidney Function Study Non-Imaging Radioisotopic Study. Managed By = Carelon
    78730Urinary Bladder Residual Study. Managed By = Carelon
    78740Ureteral Reflux Study (Radiopharmaceutical Voiding Cystogram). Managed By = Carelon
    78761Testicular Imaging With Vascular Flow. Managed By = Carelon
    78800Radiopharmaceutical Localization Of Tumor/Inflammatory Process; Planar Single Area Single Day Imaging. Managed By = Carelon
    78801Radiopharmaceutical Localization; Planar 2 Or More Areas. Managed By = Carelon
    78802Radiopharmaceutical Localization; Planar Whole Body Single Day Imaging. Managed By = Carelon
    78803Radiopharmaceutical Localization; Tomographic (SPECT) Single Area. Managed By = Carelon
    PET imaging codesCPT
    78804Radiopharmaceutical Localization; Planar Whole Body Requiring 2 Or More Days Imaging. Managed By = Carelon
    78811PET Imaging; Limited Area. Managed By = Carelon
    78812PET Imaging; Skull Base To Mid-Thigh. Managed By = Carelon
    78813PET Imaging; Whole Body. Managed By = Carelon
    78814PET With Concurrent CT; Limited Area. Managed By = Carelon
    78815PET With Concurrent CT; Skull Base To Mid-Thigh. Managed By = Carelon
    78816PET With Concurrent CT; Whole Body. Managed By = Carelon
    SPECT, CT perfusion and tomographic nuclear imagingmixed
    78830Radiopharmaceutical Localization; Tomographic (SPECT) With Concurrent CT Single Area. Managed By = Carelon
    78831Radiopharmaceutical Localization; Tomographic (SPECT) Minimum 2 Areas. Managed By = Carelon
    78832Radiopharmaceutical Localization; Tomographic (SPECT) With Concurrent CT Minimum 2 Areas. Managed By = Carelon
    0042TCerebral Perfusion Analysis Using CT With Contrast Including Post-Processing Of Parametric Maps. Managed By = Carelon
    CT breast, quantitative MRI, and radiopharmaceutical supply codesmixed
    0633TComputed Tomography Breast Including 3D Rendering Unilateral; Without Contrast Material. Managed By = Carelon
    0634TComputed Tomography Breast Including 3D Rendering Unilateral; With Contrast Material. Managed By = Carelon
    0635TComputed Tomography Breast Including 3D Rendering Unilateral; Without Contrast Followed By Contrast Material. Managed By = Carelon
    0636TComputed Tomography Breast Including 3D Rendering Bilateral; Without Contrast Material. Managed By = Carelon
    0637TComputed Tomography Breast Including 3D Rendering Bilateral; With Contrast Material. Managed By = Carelon
    0638TComputed Tomography Breast Including 3D Rendering Bilateral; Without Contrast Followed By Contrast Material. Managed By = Carelon
    0648TQuantitative MRI For Tissue Composition Single Organ. Managed By = Carelon
    0649TQuantitative MRI For Tissue Composition With Diagnostic MRI Same Anatomy; Single Organ. Managed By = Carelon
    A9602Fluorodopa F-18 Diagnostic Per Millicurie. Managed By = Carelon
    A9800Gallium Ga-68 Gozetotide Diagnostic (Locametz) Per Millicurie. Managed By = Carelon
    MR/MRA specific HCPCS C-codes (abdomen, breast, chest)HCPCS
    C8900Magnetic Resonance Angiography With Contrast Abdomen. Managed By = Carelon
    C8901Magnetic Resonance Angiography Without Contrast Abdomen. Managed By = Carelon
    C8902Magnetic Resonance Angiography Without Contrast Followed By With Contrast Abdomen. Managed By = Carelon
    C8903Magnetic Resonance Imaging With Contrast Breast; Unilateral. Managed By = Carelon
    C8905Magnetic Resonance Imaging Without Contrast Followed By With Contrast Breast; Unilateral. Managed By = Carelon
    C8906Magnetic Resonance Imaging With Contrast Breast; Bilateral. Managed By = Carelon
    C8908Magnetic Resonance Imaging Without Contrast Followed By With Contrast Breast; Bilateral. Managed By = Carelon
    C8909Magnetic Resonance Angiography With Contrast Chest (Excluding Myocardium). Managed By = Carelon
    C8910Magnetic Resonance Angiography Without Contrast Chest (Excluding Myocardium). Managed By = Carelon
    C8911Magnetic Resonance Angiography Without Contrast Followed By With Contrast Chest (Excluding Myocardium). Managed By = Carelon
    MR/MRA C-codes continued (extremities, pelvis, spine)HCPCS
    C8912Magnetic Resonance Angiography With Contrast Lower Extremity. Managed By = Carelon
    C8913Magnetic Resonance Angiography Without Contrast Lower Extremity. Managed By = Carelon
    C8914Magnetic Resonance Angiography Without Contrast Followed By With Contrast Lower Extremity. Managed By = Carelon
    C8918Magnetic Resonance Angiography With Contrast Pelvis. Managed By = Carelon
    C8919Magnetic Resonance Angiography Without Contrast Pelvis. Managed By = Carelon
    C8920Magnetic Resonance Angiography Without Contrast Followed By With Contrast Pelvis. Managed By = Carelon
    C8931Magnetic Resonance Angiography With Contrast Spinal Canal And Contents. Managed By = Carelon
    C8932Magnetic Resonance Angiography Without Contrast Spinal Canal And Contents. Managed By = Carelon
    C8933Magnetic Resonance Angiography Without Contrast Followed By With Contrast Spinal Canal And Contents. Managed By = Carelon
    Additional MRA and PET G-codesmixed
    C8934Magnetic Resonance Angiography With Contrast Upper Extremity. Managed By = Carelon
    C8935Magnetic Resonance Angiography Without Contrast Upper Extremity. Managed By = Carelon
    C8936Magnetic Resonance Angiography Without Contrast Followed By With Contrast Upper Extremity. Managed By = Carelon
    G0219PET Imaging Whole Body; Melanoma For Non-Covered Indications. Managed By = Carelon
    G0235PET Imaging Any Site Not Otherwise Specified. Managed By = Carelon
    G0252PET Imaging For Initial Diagnosis Of Breast Cancer And/Or Surgical Planning For Breast Cancer. Managed By = Carelon
    Cardiac MRI/CT and MRCPCPT/HCPCS
    S8037Magnetic Resonance Cholangiopancreatography (MRCP). Managed By = Carelon
    75557Cardiac MRI For Morphology And Function Without Contrast Material. Managed By = Carelon
    75559Cardiac MRI For Morphology And Function Without Contrast; With Stress Imaging. Managed By = Carelon
    75561Cardiac MRI Without Contrast Followed By Contrast Material(S) And Further Sequences. Managed By = Carelon
    75563Cardiac MRI Without Contrast Followed By Contrast; With Stress Imaging. Managed By = Carelon
    75565Cardiac MRI For Velocity Flow Mapping. Managed By = Carelon
    75571CT Heart Without Contrast With Quantitative Evaluation Of Coronary Calcium. Managed By = Carelon
    75572CT Heart With Contrast For Evaluation Of Cardiac Structure And Morphology. Managed By = Carelon
    75573CT Heart With Contrast For Congenital Heart Disease. Managed By = Carelon
    75574CT Angiography Heart Coronary Arteries With Contrast Including 3D Postprocessing. Managed By = Carelon
    Cardiac nuclear imaging and echocardiography codesCPT/HCPCS
    78429Myocardial Imaging PET Metabolic Evaluation With Concurrent CT. Managed By = Carelon
    78430Myocardial Imaging PET Perfusion Study With Concurrent CT. Managed By = Carelon
    78431Myocardial Imaging PET Perfusion Multiple Studies With Concurrent CT. Managed By = Carelon
    78432Myocardial Imaging PET Combined Perfusion With Metabolic Evaluation Dual Radiotracer. Managed By = Carelon
    78433Myocardial Imaging PET Combined Perfusion With Metabolic Evaluation Dual Radiotracer With Concurrent CT. Managed By = Carelon
    78451Myocardial Perfusion Imaging Tomographic (SPECT) Single Study. Managed By = Carelon
    78452Myocardial Perfusion Imaging Tomographic (SPECT) Multiple Studies. Managed By = Carelon
    78453Myocardial Perfusion Imaging Planar Single Study. Managed By = Carelon
    78454Myocardial Perfusion Imaging Planar Multiple Studies. Managed By = Carelon
    78459Myocardial Imaging PET Metabolic Evaluation Single Study. Managed By = Carelon
    1–10 of 27
    1/3
    Cardiology - PET and cardiac blood pool imagingCPT
    78491Myocardial Imaging Single Study At Rest Or Stress (Exercise Or Pharmacologic); Positron Emission Tomography Perfusion Study (Including Ventricular Wall Motion And/Or Ejection Fraction When Performed)
    78492Myocardial Imaging Multiple Studies At Rest And Stress (Exercise Or Pharmacologic); PET Perfusion Study (Including Ventricular Wall Motion And/Or Ejection Fraction When Performed)
    78494Cardiac Blood Pool Imaging Gated Equilibrium Spect At Rest Wall Motion Study Plus Ejection Fraction With Or Without Quantitative Processing
    78496Cardiac Blood Pool Imaging Gated Equilibrium Single Study At Rest With Right Ventricular Ejection Fraction By First Pass Technique
    Cardiology - Echocardiography and DopplerCPT
    93303Transthoracic Echocardiography For Congenital Cardiac Anomalies; Complete
    93304Transthoracic Echocardiography For Congenital Cardiac Anomalies; Follow-Up Or Limited Study
    93306Echocardiography Transthoracic Real-Time With Image Documentation (2D) Complete With Spectral Doppler And Color Flow Doppler
    93307Echocardiography Transthoracic Real-Time With Image Documentation (2D) Complete Without Spectral Or Color Doppler
    93308Echocardiography Transthoracic Real-Time With Image Documentation (2D) Follow-Up Or Limited Study
    93312Echocardiography Transesophageal Real-Time With Image Documentation (2D) (With Or Without M-Mode Recording); Including Probe Placement Image Acquisition Interpretation And Report
    93313Echocardiography Transesophageal Real-Time With Image Documentation (2D); Placement Of Transesophageal Probe Only
    93314Echocardiography Transesophageal Image Acquisition Interpretation And Report Only
    93315Transesophageal Echocardiography For Congenital Cardiac Anomalies; Including Probe Placement Image Acquisition Interpretation And Report
    93316Transesophageal Echocardiography For Congenital Cardiac Anomalies; Placement Of Transesophageal Probe Only
    1–10 of 17
    1/2
    Ear, Nose, and Throat (ENT) - surgical and device codesmixed
    30120Excision Or Surgical Planing Of Skin Of Nose For Rhinophyma
    30400Rhinoplasty Primary; Lateral And Alar Cartilages And/Or Elevation Of Nasal Tip
    30410Rhinoplasty Primary; Complete External Parts Including Bony Pyramid Lateral And Alar Cartilages And/Or Elevation Of Nasal Tip
    30420Rhinoplasty Primary; Including Major Septal Repair
    30430Rhinoplasty Secondary; Minor Revision
    30435Rhinoplasty Secondary; Intermediate Revision (Bony Work With Osteotomies)
    30450Rhinoplasty Secondary; Major Revision (Nasal Tip Work And Osteotomies)
    30999Unlisted Procedure Nose
    31296Nasal/Sinus Endoscopy Surgical With Dilation; Frontal Sinus Ostium
    31297Nasal/Sinus Endoscopy Surgical With Dilation; Sphenoid Sinus Ostium
    1–10 of 30
    1/3
    Gastroenterology - gastric neurostimulator procedures and devicesmixed
    43647Laparoscopy Surgical; Implantation Or Replacement Of Gastric Neurostimulator Electrodes Antrum
    43648Laparoscopy Surgical; Revision Or Removal Of Gastric Neurostimulator Electrodes Antrum
    43881Implantation Or Replacement Of Gastric Neurostimulator Electrodes Antrum Open
    95980Electronic Analysis Of Implanted Neurostimulator Pulse Generator System Gastric Neurostimulator Pulse Generator/Transmitter; Intraoperative With Programming
    E0765FDA Approved Nerve Stimulator With Replaceable Batteries For Treatment Of Nausea And Vomiting
    Home Infusion Therapy - per diem and hourly service codesHCPCS
    S5501Home infusion therapy, catheter care/maintenance, complex (more than one lumen), per diem
    S5502Home infusion therapy, catheter care/maintenance, implanted access device, per diem
    S9208Home management of preterm labor, per diem
    S9209Home management of preterm premature rupture of membranes (PPROM), per diem
    S9211Home management of gestational hypertension, per diem
    S9212Home management of postpartum hypertension, per diem
    S9213Home management of preeclampsia, per diem
    S9214Home management of gestational diabetes, per diem
    S9325Home infusion therapy, pain management infusion; per diem
    S9357Home infusion therapy, enzyme replacement intravenous therapy; per diem
    1–10 of 22
    1/3
    Molecular Genetic Lab Testing (PLA codes)PLA
    0552UReproductive medicine (preimplantation genetic assessment), analysis for known genetic disorders from trophectoderm biopsy, linkage analysis and targeted mutation analysis, reported as low-risk or high-risk for familial genetic disorder
    0553UReproductive medicine (preimplantation genetic assessment), analysis of 24 chromosomes using DNA genomic sequence analysis from embryonic trophectoderm for structural rearrangements, aneuploidy, and a mitochondrial DNA score, per embryo tested
    0554UReproductive medicine (preimplantation genetic assessment), analysis of 24 chromosomes using DNA genomic sequence analysis from trophectoderm biopsy for aneuploidy, ploidy, a mitochondrial DNA score, and embryo quality control, per embryo tested
    0555UReproductive medicine (preimplantation genetic assessment), analysis of 24 chromosomes using DNA genomic sequence analysis for structural rearrangements, aneuploidy, ploidy, mitochondrial DNA score, and embryo quality control, per embryo tested
    Audiology - to be retiredCPT
    92633Auditory Rehabilitation; Postlingual Hearing Loss (Retire Effective 01/01/2025)
    U-codes and select CPT codes added/managedmixed
    0552UReproductive medicine (preimplantation genetic assessment), analysis for known genetic disorders from trophectoderm biopsy, linkage analysis of disease-causing locus, and when possible, targeted mutation analysis for known familial variant, reported as low-risk or high-risk for familial genetic disorder.
    0553UReproductive medicine (preimplantation genetic assessment), analysis of 24 chromosomes using DNA genomic sequence analysis from embryonic trophectoderm for structural rearrangements, aneuploidy, and a mitochondrial DNA score, results reported as normal/balanced (euploidy/balanced), unbalanced structural rearrangement, monosomy, trisomy, segmental aneuploidy, or mosaic, per embryo tested.
    0554UReproductive medicine (preimplantation genetic assessment), analysis of 24 chromosomes using DNA genomic sequence analysis from trophectoderm biopsy for aneuploidy, ploidy, a mitochondrial DNA score, and embryo quality control, results reported as normal (euploidy), monosomy, trisomy, segmental aneuploidy, triploid, haploid, or mosaic, with quality control results reported as contamination detected or inconsistent cohort when applicable, per embryo tested.
    0555UReproductive medicine (preimplantation genetic assessment), analysis of 24 chromosomes using DNA genomic sequence analysis from embryonic trophectoderm for structural rearrangements, aneuploidy, ploidy, a mitochondrial DNA score, and embryo quality control, results reported as normal/balanced (euploidy/balanced), unbalanced structural rearrangement, monosomy, trisomy, segmental aneuploidy, triploid, haploid, or mosaic, with quality control results reported as contamination detected or inconsistent cohort when applicable, per embryo tested.
    0560UOncology (minimal residual disease [MRD]), genomic sequence analysis, cell-free DNA, whole blood and tumor tissue, baseline assessment for design and construction of a personalized variant panel to evaluate current MRD and for comparison to subsequent MRD assessments.
    0561UOncology (minimal residual disease [MRD]), genomic sequence analysis, cell-free DNA, whole blood, subsequent assessment with comparison to initial assessment to evaluate for MRD.
    0562UOncology (solid tumor), targeted genomic sequence analysis, 33 genes, detection of SNVs, insertions and deletions, copy-number amplifications, and translocations in circulating cell-free DNA, plasma, reported as presence of actionable variants.
    0565UOncology (hepatocellular carcinoma), next-generation sequencing methylation pattern assay to detect 6626 epigenetic alterations, cell-free DNA, plasma, algorithm reported as cancer signal detected or not detected.
    0566UOncology (lung), qPCR-based analysis of 13 differentially methylated regions in pleural fluid, algorithm reported as a qualitative result.
    0567URare diseases (constitutional/heritable disorders), whole-genome sequence analysis combination of short and long reads for multiple variant types and methylation status from various sample types.
    1–10 of 13
    1/2
    Covered/Listed CPT genetic test codesCPTCovered
    81120Idh1 (Isocitrate Dehydrogenase 1) Common Variants (e.g., R132H R132C).
    81121Idh2 (Isocitrate Dehydrogenase 2) Common Variants (e.g., R140W R172M).
    81162Brca1/Brca2 Gene Analysis; Full Sequence Analysis And Full Duplication/Deletion Analysis (Detection Of Large Gene Rearrangements).
    81163Brca1/Brca2 Gene Analysis; Full Sequence Analysis.
    81164Brca1/Brca2 Gene Analysis; Full Duplication/Deletion Analysis (Detection Of Large Gene Rearrangements).
    81165Brca1 Gene Analysis; Full Sequence Analysis.
    81166Brca1 Gene Analysis; Full Duplication/Deletion Analysis (Detection Of Large Gene Rearrangements).
    81167Brca2 Gene Analysis; Full Duplication/Deletion Analysis (Detection Of Large Gene Rearrangements).
    81168Ccnd1/Igh (T(11;14)) Translocation Analysis Major Breakpoint Qualitative And Quantitative If Performed.
    81170Abl1 Gene Analysis Variants In The Kinase Domain.
    1–10 of 70
    1/7
    Effective date — site-of-care update
    Effective date01/01/2025
    ScopeAddition of site-of-care requirement to medical necessity criteria for multiple advanced imaging CPT codes
    Managed byCarelon (utilization management oversight for affected codes)
    PLA codes — effective date
    PLA codes0552U, 0553U, 0554U, 0555U
    Effective date for PLA codes10/01/2025 (Add effective 10/1/2025)
    Managed byCarelon
    Code retirement
    Retired code92633
    Retirement effective01/01/2025
    Managed by prior to retirementBCBSOK
    Per-embryo reporting requirement
    Reporting unitPer embryo tested
    Applies to codes0553U, 0554U, 0555U
    Test description noteResults reported as euploid/abnormal, structural rearrangements, mosaicism, or quality-control flags per embryo
    Minimum genes — mitochondrial panel (81440)
    Minimum gene count>= 100 genes
    Applies to code81440 (Nuclear encoded mitochondrial genes genomic sequence panel)
    Example genes includedBCS1L, C10ORF2, COQ2, COX10, DGUOK, MPV17, OPA1, PDSS2, POLG, POLG2
    Minimum genes — inherited bone marrow failure panel (81441)
    Minimum gene count>= 30 genes
    Applies to code81441 (Inherited bone marrow failure syndromes panel)
    Example genes includedBRCA2, BRIP1, DKC1, FANCA, FANCB (among others listed in policy)
    Minimum genes — hearing loss panel (81430)
    Minimum gene count>= 60 genes
    Applies to code81430 (Hearing loss genomic sequence analysis panel)
    Example genes includedCDH23, CLRN1, GJB2, GPR98, MTRNR1, MYO7A, MYO15A, PCDH15, OTOF, SLC26A4

    Provider Actions, Authorization & Documentation

    Prior Authorization

    Prior authorization may be required for listed codes (effective 01/01/2025)

    Prior authorization may be required for the listed CPT codes; the document lists numerous advanced imaging/radiology CPTs and states prior authorization may be required as of January 1, 2025.

    Prior Authorization

    Carelon manages PA — site-of-care added to medical necessity

    Prior authorization/management for the listed advanced imaging CPT codes is handled by Carelon; medical necessity criteria were updated to add site-of-care as a required element effective 01/01/2025.

    Prior Authorization

    Carelon-managed codes — follow Carelon authorization processes

    These specific procedure codes are managed by Carelon for utilization management; prior authorization or utilization management through Carelon is indicated for the listed codes.

    Prior Authorization

    Follow the 'Managed By' designation for authorization routing

    Prior authorization and management requirements are governed by the entity listed in each code's 'Managed By' field; entries show codes may be managed by Carelon or BCBSOK and should be routed accordingly.

    Prior Authorization

    Route PA requests for listed molecular genetic U-codes to Carelon

    Specified U-codes and select CPT/PLA codes (e.g., 0552U–0555U and other 05xxx U-codes) are assigned to Carelon for utilization management and include 'Add effective' dates; providers should route authorization/management requests to Carelon for those entries.

    Prior Authorization

    Molecular genetic CPT codes labeled 'Managed By = Carelon' — PA applies

    Prior authorization/management oversight is indicated for the listed molecular genetic CPT codes in the 81230–81328 and 81400 series; these entries are labeled 'Managed By = Carelon.'

    Prior Authorization

    CPT molecular pathology codes — managed by Carelon

    These CPT codes in the molecular genetics/molecular pathology groups are listed with 'Managed By = Carelon'; providers must follow Carelon's utilization management procedures for authorization and review.

    Prior Authorization

    Category III/U-codes — Carelon manages utilization and PA

    Entries in the Category III (U-code) ranges are marked 'Managed By = Carelon', indicating these molecular genetic lab testing codes are subject to Carelon utilization management and prior authorization processes where applicable.

    Prior Authorization

    81558 — management update (Add effective 04/01/2025); PA applies

    Code 81558 (transplantation medicine mRNA gene expression profiling) is listed with 'Updates = Add effective 04/01/2025', indicating a management update effective on that date and that prior authorization under Carelon rules will apply when effective.

    Prior Authorization

    Category III molecular/genetic tests — PA/UM by Carelon

    Category III molecular/genetic lab tests in the listed ranges are identified as managed by Carelon and are therefore subject to utilization management processes often requiring administrative review/prior authorization.

    Prior Authorization

    U-codes (198–217) — Managed by Carelon; follow Carelon PA process

    Listed U-codes in chunks 198–217 are identified as 'Managed By = Carelon'; providers should follow Carelon prior authorization procedures for these tests.

    Prior Authorization

    U-codes and molecular tests — submit authorizations to Carelon

    These U-codes and other molecular genetic entries are listed under utilization management and are managed by Carelon; providers should submit authorization requests to Carelon as indicated.

    Prior Authorization

    0627T–0630T (percutaneous disc injections) — PA via Carelon when effective 10/01/2025

    Percutaneous allogeneic cellular/tissue intervertebral disc injection codes (0627T–0630T) are added and managed by Carelon with an effective date of 10/01/2025; Carelon prior authorization processes will apply when these codes are effective.

    Prior Authorization

    Multiple listed codes — Managed By = Carelon (follow Carelon processes)

    Codes listed in various imaging and procedural sections are identified as 'Managed By = Carelon', indicating management (including prior authorization) is delegated to Carelon for those service codes.

    Prior Authorization

    27412 — Prior authorization required through Carelon

    Prior authorization is required through Carelon for CPT 27412 (Autologous Chondrocyte Implantation, Knee); the entry explicitly notes prior authorization required through Carelon.

    Documentation Required

    File is searchable by code or description

    This file is a searchable PDF; providers can search by procedure code or description to identify whether a given service requires prior authorization.

    Documentation Required

    Document site-of-care on authorization requests (effective 01/01/2025)

    Medical necessity determinations for the listed codes now include site-of-care as a required criterion effective 01/01/2025; providers should document site-of-care when requesting authorization.

    Documentation Required

    Submit authorization/claims using the exact listed procedure code and follow 'Managed By' routing

    Providers must submit claims and authorization requests using the exact procedure codes shown in the list; utilization management for these codes is managed by the entity shown in each 'Managed By' field (e.g., Carelon).

    Documentation Required

    Provide supportive clinical documentation that matches the billed code

    Documentation should support the specific CPT/HCPCS/PLA code billed; code descriptions in the file indicate required procedure/test details that must be reflected in the clinical record or order.

    Documentation Required

    Use the code-level 'Managed By' designation to determine authorization manager

    Each listed code entry includes a 'Managed By' assignment (predominantly 'Managed By = Carelon'); providers should follow the designated manager's utilization management procedures for authorization and appeals.

    Note
    Documentation Required

    Ensure panel composition meets code-specific minimum gene list

    CPT entries for genomic sequence analysis panels specify minimum required gene content for certain panels (examples: 81410 requires sequencing of at least 9 named genes; 81430 requires at least 60 genes; 81440 requires at least 100 genes) and providers must ensure panel composition meets the code-specific requirements.

    Documentation Required

    'Managed By = Carelon' noted on each code — follow Carelon procedures

    Each molecular genetic code entry includes a short description and a 'Managed By = Carelon' designation; providers should follow Carelon's utilization management and authorization procedures for these tests.

    Documentation Required

    Document specimen type and report expectations on the order

    Tests list specimen types and expected report formats (e.g., plasma, whole blood, saliva, FFPE tissue, per-embryo reporting for 0553U–0555U); providers should document specimen type on orders and in the clinical record.

    Documentation Required

    Follow Carelon's authorization procedures and respect effective/retire dates

    Providers should follow Carelon's utilization management procedures as indicated by the 'Managed By = Carelon' designation for listed codes and ensure coding aligns with effective and retire dates shown in the file.

    Denial Risk

    PA may be required for advanced imaging codes (01/01/2025)

    Prior authorization may be required for the listed advanced imaging/radiology procedure codes effective 01/01/2025; failure to obtain prior authorization when required may trigger claim denial or coverage delay.

    Denial Risk

    Denial risk if site-of-care not documented

    Claims or authorizations for the listed advanced imaging CPT codes may be denied or require review if medical necessity criteria (which now include site-of-care) are not met; document site-of-care to reduce denial risk.

    • Site-of-care must be included in medical necessity documentation (effective 01/01/2025).
    Denial Risk

    Carelon-managed codes — risk of denial without Carelon authorization

    Claims for the listed procedure codes may be subject to utilization management by Carelon and could be denied if not authorized or managed per Carelon processes.

    Denial Risk

    Managed-by designation affects authorization and denial risk

    Claims for codes listed as 'Managed By = Carelon' or 'Managed By = BCBSOK' may be subject to that manager's utilization management rules; failure to comply with the assigned manager's requirements may trigger denial.

    Denial Risk

    Route authorizations correctly — misrouting to BCBSOK vs Carelon may cause denial

    Tests or codes delegated to Carelon but routed incorrectly (not submitted to Carelon) could result in denial if prior authorization/management was required but not obtained.

    Denial Risk

    Molecular genetic tests — potential denial without Carelon authorization

    Claims for the listed molecular genetic CPT codes and U-codes may be managed by Carelon; lack of authorization or failure to follow Carelon processes could trigger claim denial.

    Denial Risk

    Retired codes — risk of different handling after retire dates

    Codes marked 'Retire Effective' (examples: codes with retirement dates such as 92633 retire effective 01/01/2025 or select U-codes retired 04/01/2025 or 07/01/2025) may be handled differently after retirement dates and could affect coverage/authorization.

    • 92633 — Retire Effective 01/01/2025
    • 0456U — Retire Effective 04/01/2025
    • 0078U — Retire Effective 07/01/2025
    Denial Risk

    Carelon utilization management may deny services not meeting review criteria

    Services billed with the listed codes are managed by Carelon; claims or requests for listed molecular genetic tests may be subject to Carelon utilization management review and potentially denied if not meeting that reviewer’s policies.

    Denial Risk

    UM oversight and code effective/retire dates affect adjudication

    Claims for the listed molecular genetic tests may be subject to utilization management oversight by Carelon; codes marked as 'Retire' or with future effective dates may affect claim adjudication if billed outside effective periods.

    Note

    Prior Authorization Requirements and Routing

    Prior Authorization

    MRI/CT/CTA/MRA — PA may be required via Carelon (effective 01/01/2025)

    Prior authorization may be required for listed MRI/CT/CTA/MRA CPT codes effective 01/01/2025 and these are managed by Carelon; obtain authorization from Carelon when indicated.

    Prior Authorization

    Advanced imaging — Carelon evaluates medical necessity including site-of-care

    Advanced imaging CPTs shown in the list are managed by Carelon and medical necessity evaluation for these codes includes site-of-care as a review element.

    Prior Authorization

    Multiple imaging modalities — Carelon-managed PA

    Multiple listed modalities (CT, MRI, MRA, PET, nuclear medicine, echocardiography) are indicated as prior authorization/managed by Carelon; follow Carelon processes for authorization.

    Prior Authorization

    PET/echo/PLA testing — follow assigned manager for PA

    For PET, echocardiography, and PLA molecular testing entries, prior authorization/management is assigned to the entity shown for each code; submit requests to that manager (often Carelon).

    Prior Authorization

    Molecular genetic lab tests — submit PA to 'Managed By' entity (Carelon)

    For molecular genetic laboratory testing codes (81400 series and others) the file directs providers to submit authorization/management requests to the entity listed in 'Managed By' (predominantly Carelon).

    Prior Authorization

    81400-series molecular pathology codes — managed by Carelon (PA implied)

    Molecular genetic CPT codes in the 81400 series are labeled 'Managed By = Carelon' indicating administrative/authorization review is implied for many entries in that series.

    Prior Authorization

    Molecular genetic lab testing — Carelon management and PA processes implied

    Management by Carelon is indicated for many molecular genetic lab testing codes, implying administrative/prior authorization processes apply; providers should follow Carelon rules.

    Prior Authorization

    U-codes — Carelon manages utilization and PA

    Listed U-codes for molecular genetic testing are managed by Carelon; utilization management applies and providers should follow Carelon prior authorization procedures.

    Prior Authorization

    Molecular genetic tests (various) — PA via Carelon

    Various molecular genetic tests and U-codes across the document are managed by Carelon; providers should submit authorization requests to Carelon per the 'Managed By' field.

    Prior Authorization

    0627T–0630T — PA required via Carelon when effective 10/01/2025

    Percutaneous allogeneic intervertebral disc injection codes 0627T–0630T will require prior authorization when they become effective on 10/01/2025 and are managed by Carelon.

    Note
    Note

    Carelon manages listed codes — follow Carelon for PA thresholds

    Codes listed are managed by Carelon (delegated); the excerpt does not provide numeric PA thresholds — follow Carelon's authorization rules for specifics.

    Contrast/Non-Contrast Coding Notes

    Billing Rule

    Contrast status indicated per CPT (with/without/followed by contrast)

    Code descriptions indicate contrast status (with/without/followed by contrast) for many CPTs; prior authorization applicability is listed per CPT code and reflects the code's contrast variant.

    Billing Rule

    Use the exact CPT variant that reflects contrast technique

    Codes include both contrast and non-contrast variants and sequences (non-contrast followed by contrast); providers must use the exact CPT that matches the contrast technique performed when requesting authorization.

    Billing Rule

    Bill the specific contrast variant code (C-/T- variants) shown in the file

    Multiple T- and C-codes specify 'with' or 'without' contrast variants and post-processing; these are listed separately and managed by Carelon — billers and providers must select the correct code for authorization and claims.

    Billing Rule

    93352 — use this code when echocardiographic contrast agent is administered (managed by Carelon)

    Use of echocardiographic contrast agent during stress echocardiography is represented by code 93352 (listed as 'Use Of Echocardiographic Contrast Agent During Stress Echocardiography') and is managed by Carelon; submit authorization/claims using that code when contrast agent is used.

    Background and Scope

    Background: This policy segment enumerates a broad set of advanced imaging CPT codes across modalities—including CT, MRI/MRA, PET, nuclear medicine, and ultrasound—and indicates that these codes are subject to utilization management. A material operational change noted in the revision history is the addition of site-of-care as an element of medical necessity criteria effective 01/01/2025, and the document consolidates effective-date and code additions/retirements in the changes list for revision history.

    Definitions and Key Terms

    Definition — Site of care
    DefinitionSite of care — the location where the service is performed; included in medical necessity determinations for listed advanced imaging CPT codes effective 01/01/2025
    Operational impactProviders must document site-of-care on authorization requests and claims where required
    Managed byCarelon (utilization management for affected codes)
    Definition — Managed By
    Field meaning'Managed By' indicates which utilization management entity (Carelon or BCBSOK) administers prior authorization and utilization review for the listed code
    Common assignmentMajority of listed molecular/genetic and advanced imaging codes: Managed By = Carelon
    Provider actionRoute prior authorization requests to the entity named in 'Managed By' for each code
    Definition — Preimplantation genetic assessment (0553U/0554U/0555U)
    Family descriptionPreimplantation genetic assessment family — analysis of 24 chromosomes from embryonic trophectoderm for aneuploidy, structural rearrangements, mitochondrial DNA score, and embryo quality control
    Representative codes0552U, 0553U, 0554U, 0555U
    Reporting unitResults reported per embryo tested (0553U–0555U) and managed by Carelon
    Definition — Oncology MRD (0560U / 0561U)
    Service descriptionOncology MRD — genomic sequence analysis of cell-free DNA (cfDNA) for baseline and subsequent assessments to detect minimal residual disease
    Representative codes0560U (baseline design of personalized variant panel), 0561U (subsequent assessment)
    Specimen typesCell-free DNA (plasma), whole blood and tumor tissue as described in code entries
    Definition — Molecular Genetic Lab Testing
    Service categoryMolecular Genetic Lab Testing — genetic tests analyzing specific genes, variants, promoter methylation, rearrangements, repeat expansions, or copy number changes
    IncludesCPT series 812xx–814xx, U-codes and other molecular pathology/PLA entries listed in policy
    Managed byCarelon for the majority of entries in this category
    Definition — Molecular Pathology Procedure Levels
    DefinitionMolecular Pathology Procedure Levels (81400–81405) — Levels 1–6 defined by complexity and number/type of variants analyzed
    ExamplesLevel 1 = single germline variant detection; Level 6 = analysis of 6–10 exons or regionally targeted cytogenomic array
    Codes81400–81405 denote these procedure levels in the policy
    Definition — Genomic sequence analysis panel
    DefinitionGenomic sequence analysis panel — a panel that sequences multiple genes related to a specified hereditary condition and, when specified, must include sequencing of a minimum named gene set
    Policy requirementWhen a minimum gene count/list is specified for a CPT panel code, the panel must include those genes to meet ordering/coverage expectations
    ExamplesSee code-specific entries (e.g., 81410, 81430, 81440) for required gene lists and minimum counts
    Definition — Managed By = Carelon
    Managed By = CarelonIndicates utilization management for that specific code is delegated to Carelon
    ImplicationProviders should submit prior authorization requests and supporting documentation to Carelon when codes show this assignment
    PrevalenceMajority of molecular genetic and U-code listings are noted as Managed By = Carelon in this document
    Definition — U-code descriptions (PLA/Category III)
    DefinitionU-code descriptions (PLA/CPT Category I descriptive codes) — textual descriptors used to identify specific molecular genetic lab tests and panels
    PurposeUsed in this policy to label new/emerging laboratory tests (U-codes/PLA) with descriptions, specimen types, and management assignment
    Examples0552U–0555U and many other 0###U codes are listed with descriptions and 'Managed By' fields
    Definition — U-code (HCPCS Category III)
    DefinitionU-code — HCPCS temporary (Category III) code used for emerging or new medical technologies/tests
    Usage in policyDocument lists many U-codes with descriptions and Managed By assignments; effective/retire dates are included where applicable
    Provider actionFollow 'Managed By' routing for authorization of services billed with U-codes
    Definition — cell-free DNA (cfDNA)
    DefinitionCell-free DNA (cfDNA) — circulating DNA fragments (often plasma) analyzed for tumor, fetal, or transplant-derived signals as described in specific U-code/CPT entries
    ExamplesUsed in MRD assays (0560U/0561U), fetal aneuploidy tests (0327U), and multiple oncology cfDNA panels listed in the policy
    Specimen typesPlasma (cfDNA), whole blood, and tumor tissue as specified per test
    Definition — next-generation sequencing (NGS)
    DefinitionNext-generation sequencing (NGS) — high-throughput DNA/RNA sequencing methods used to detect sequence variants, copy number changes, rearrangements, methylation and other genomic features
    UsageReferenced across many CPT/U-code entries for targeted panels, exome/genome sequencing, and cfDNA assays (e.g., 0473U, 0334U, 0329U)
    ImplicationNGS-based panels may have specified gene counts or required analytic scope per code to meet coverage expectations
    Definition — Molecular Pathology Procedure Levels (additional)
    DefinitionMolecular Pathology Procedure Levels (Levels 1–6) — defined by complexity and number/type of variants analyzed; used to categorize molecular pathology services
    Range81400–81405 represent Levels 1–6 in the CPT molecular pathology series
    ExamplesLevel 1: single germline variant detection; Level 6: analysis of 6–10 exons or regionally targeted cytogenomic array

    Policy Update Changes

    Revision summary (high level): the file consolidates multiple policy updates and effective dates. Notable operational changes include the addition of site-of-care to medical necessity criteria effective 01/01/2025 for many advanced imaging CPT codes, plus numerous molecular/U-code additions and retirements with effective dates (examples shown across the code listings). See the document’s changes/revision-history section for the full list of affected codes and their effective or retirement dates.

    Policy Summary
    PayerBlue Cross Blue Shield - Oklahoma
    PolicyAdvanced Imaging / Radiology prior authorization code list
    Policy CodePolicy N/A
    Change TypeMaterial updates to code management and criteria
    Effective DateJan 1, 2025
    Next Review DateN/A
    Key ActionDocument medical necessity requests with site-of-care and route prior authorization requests to the entity listed in 'Managed By' (predominantly Carelon).
    SourceLink
    On This Page
    Coverage Criteria and Management AssignmentsCode Listings and Effective DatesProvider Actions, Authorization & DocumentationPrior Authorization Requirements and RoutingContrast/Non-Contrast Coding NotesBackground and ScopeDefinitions and Key TermsPolicy Update Changes

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.